http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104860945-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e74277852f1aae0a3ff13f59a65456d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-06
filingDate 2014-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40273f5cc3b6eb0b1a927f19b3e8ddee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d653465bff543af79db04802ad16bb7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58613e0ea843508c078f8f2afcb85395
publicationDate 2015-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104860945-A
titleOfInvention Fused acridine derivatives, pharmaceutical composition, preparation method and application thereof
abstract The invention discloses a new class of fused acridine derivatives, such as the compound of formula (I), which has good antitumor activity, and the definition of each group is detailed in the description. In addition, the invention also discloses the preparation method and application of the derivative as well as the pharmaceutical composition and application containing the derivative
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108853102-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108853102-A
priorityDate 2014-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0109133-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466322264

Total number of triples: 21.